NFKB1 and hyperlipidemia: Lipidomics analysis showed that these beneficial effects of AEE in hyperlipidemia mice were associated with the downregulation of PEs and SMs in the liver, and were mediated mainly through the glycerophospholipid metabolic pathway, sphingolipid signaling pathway, and NF-kB signaling pathway.